Migraine treatment device launched

New US Food and Drug Administration (FDA) approved migraine treatment device, Cefaly Dual, was launched in Bahrain by Gulf Markets International (GMI) at the Swiss-Belhotel Seef. Read More  

New US Food and Drug Administration (FDA) approved migraine treatment device, Cefaly Dual, was launched in Bahrain by Gulf Markets International (GMI) at the Swiss-Belhotel Seef.

Read More